Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CHYMOTRYPSIN
- Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal
- Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis
- Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
- Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery
- Comparing Trypsin-Chymotrypsin and Naproxen Sodium for Post-endodontic Treatment Pain
- A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy
- The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain
- Healing Potentiality of Trypsin and Alpha Chemo Trypsin in Mandibular Molars With Chronic Apical Abscess
- CDI-988 Safety Study in Healthy Participants
- Efficacy of Trypsin-Chymotrypsin On Post-operative Pain After Single Visit Root Canal Treatment
- Investigation the Effect of Montelukast in COVID-19
- DEFINE - Evaluating Therapies for COVID-19
- Treatment of Mild-moderate Clostridium Difficile Infection (CDI)
- An Open Label Study of CM-AT for the Treatment of Children With Autism
- A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
- A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)
- Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors
- Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
- Multi-Drug Desensitization Protocol for Heart Transplant Candidates
- Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma
- Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
- The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
Clinical trials list
click for details